Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 44 studies | 43% ± 15% | |
pericyte | 30 studies | 37% ± 17% | |
fibroblast | 28 studies | 35% ± 14% | |
smooth muscle cell | 18 studies | 34% ± 16% | |
endothelial cell of lymphatic vessel | 15 studies | 39% ± 16% | |
capillary endothelial cell | 15 studies | 40% ± 13% | |
endothelial cell of artery | 13 studies | 38% ± 19% | |
vein endothelial cell | 13 studies | 29% ± 18% | |
oligodendrocyte | 10 studies | 27% ± 10% | |
myofibroblast cell | 9 studies | 35% ± 13% | |
endothelial cell of vascular tree | 9 studies | 37% ± 19% | |
ciliated cell | 7 studies | 28% ± 11% | |
macrophage | 7 studies | 30% ± 13% | |
epithelial cell | 7 studies | 40% ± 23% | |
astrocyte | 5 studies | 30% ± 12% | |
adipocyte | 5 studies | 32% ± 7% | |
connective tissue cell | 5 studies | 42% ± 10% | |
glomerular endothelial cell | 4 studies | 42% ± 3% | |
retinal pigment epithelial cell | 4 studies | 52% ± 17% | |
cardiac muscle cell | 4 studies | 19% ± 2% | |
mesothelial cell | 4 studies | 32% ± 13% | |
muscle cell | 4 studies | 30% ± 5% | |
goblet cell | 4 studies | 33% ± 23% | |
basal cell | 4 studies | 45% ± 25% | |
microglial cell | 4 studies | 39% ± 22% | |
hepatic stellate cell | 3 studies | 37% ± 19% | |
abnormal cell | 3 studies | 26% ± 12% | |
glial cell | 3 studies | 20% ± 4% | |
squamous epithelial cell | 3 studies | 35% ± 16% | |
adventitial cell | 3 studies | 31% ± 9% | |
transit amplifying cell | 3 studies | 42% ± 37% | |
podocyte | 3 studies | 69% ± 10% | |
renal principal cell | 3 studies | 26% ± 8% | |
secretory cell | 3 studies | 32% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 9388.29 | 459 / 459 | 99% | 24.86 | 1107 / 1118 |
prostate | 100% | 5872.82 | 244 / 245 | 99% | 16.18 | 498 / 502 |
uterus | 100% | 5931.81 | 170 / 170 | 97% | 17.30 | 446 / 459 |
esophagus | 100% | 5388.09 | 1439 / 1445 | 97% | 19.86 | 178 / 183 |
thymus | 100% | 9644.15 | 653 / 653 | 96% | 53.38 | 583 / 605 |
kidney | 100% | 6399.02 | 89 / 89 | 96% | 35.26 | 863 / 901 |
ovary | 100% | 7921.45 | 180 / 180 | 94% | 16.35 | 406 / 430 |
lung | 100% | 8116.81 | 578 / 578 | 93% | 13.51 | 1077 / 1155 |
intestine | 97% | 3669.18 | 940 / 966 | 96% | 16.14 | 505 / 527 |
stomach | 98% | 3404.17 | 351 / 359 | 94% | 16.81 | 270 / 286 |
skin | 100% | 5675.57 | 1802 / 1809 | 92% | 21.22 | 434 / 472 |
adrenal gland | 98% | 3695.50 | 252 / 258 | 90% | 13.96 | 207 / 230 |
bladder | 95% | 3485.57 | 20 / 21 | 90% | 12.11 | 454 / 504 |
pancreas | 69% | 1636.92 | 226 / 328 | 97% | 26.78 | 173 / 178 |
liver | 53% | 1162.26 | 119 / 226 | 77% | 8.63 | 311 / 406 |
brain | 37% | 918.69 | 980 / 2642 | 80% | 8.30 | 562 / 705 |
blood vessel | 100% | 12862.86 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 19499.15 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6929.73 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.15 | 1 / 1 |
adipose | 100% | 9933.12 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 4198.49 | 848 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 14.38 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 53% | 7.43 | 42 / 80 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.75 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901223 | Biological process | negative regulation of non-canonical NF-kappaB signal transduction |
GO_0008150 | Biological process | biological_process |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | UACA |
Protein name | UACA protein Uveal autoantigen with coiled-coil domains and ankyrin repeats |
Synonyms | KIAA1561 |
Description | FUNCTION: Regulates APAF1 expression and plays an important role in the regulation of stress-induced apoptosis. Promotes apoptosis by regulating three pathways, apoptosome up-regulation, LGALS3/galectin-3 down-regulation and NF-kappa-B inactivation. Regulates the redistribution of APAF1 into the nucleus after proapoptotic stress. Down-regulates the expression of LGALS3 by inhibiting NFKB1 (By similarity). .; FUNCTION: Modulates isoactin dynamics to regulate the morphological alterations required for cell growth and motility. Interaction with ARF6 may modulate cell shape and motility after injury. May be involved in multiple neurite formation (By similarity). . |
Accessions | ENST00000322954.11 [Q9BZF9-1] ENST00000379983.6 [Q9BZF9-2] H0YMI1 B7ZKM7 ENST00000560167.1 ENST00000558758.5 Q05DB3 F5H2B9 H0YN48 ENST00000560441.5 Q9BZF9 H0YNH8 B7ZKM6 ENST00000539319.5 |